Binge Eating Disorder Market Size and Share Outlook - Forecast Trends and Growth Analysis Report (2024-2032)

Binge Eating Disorder Market Outlook

• The rising prevalence of eating disorders is a primary driver of the market. As per the Eating Recovery Center’s Eating Disorder Statistics 2024, 28.8 million Americans, or 9% of the United States population will experience an eating disorder at some point in their lives.
• Providing adequate education about the condition and its treatment is amongst the major market trends. For instance, Monte Nido & Affiliates, a leading eating disorder treatment provider in the United States educated on binge eating disorder during National Eating Disorders Awareness Week in February 2024.
• The robust regulatory support from health authorities like the FDA and ongoing research and development efforts to improve therapeutic options for binge eating disorders are likely to elevate the market value in the forecast period.

Binge Eating Disorder Market Overview

Binge eating disorder (BED) is characterized by excessive eating within a short period, without engaging in purging behaviors such as vomiting. It can result in obesity, heart disease, and emotional problems. BED is the result of a combination of genetic, psychological, and environmental factors such as genetics, lack of self-confidence, and societal influences. Binge episodes can be exacerbated by stress and negative emotions.

Genetic factors, hormonal imbalances, and dopamine are all factors that influence the development and severity of the disorder. Mental health problems such as depression, anxiety, and previous trauma can lead to episodes of binge eating, along with emotional stressors. Societal expectations, limited eating habits, and genetic predisposition for eating disorders may elevate the chances of developing one. 

Binge eating disorder treatment typically includes a mix of counseling, drugs, and adjustments in lifestyle. Cognitive behavioral therapy (CBT) is successful in handling triggers, while drugs such as lisdexamfetamine and antidepressants aid in diminishing cravings and balancing mood. 

Binge Eating Disorder Market Growth Drivers

Increasing Prevalence of Binge Eating Disorder Spurs Market Growth

The rising occurrence of binge eating disorder is driving the growth of the market as awareness of mental health increases. As per the Eating Recovery Center’s eating disorder statistics for 2024, 28.8 million Americans, or 9% of the U.S. population, will experience an eating disorder at some point in their lives. Each year, 10,200 deaths occur due to eating disorders, resulting in one death every 52 minutes. Urbanization, inactive lifestyles, and high-stress levels lead to a rise in BED cases, particularly in developed areas. 

Growing Awareness and Diagnosis to Meet Rising Binge Eating Disorder Market Demand

Efforts in public health campaigns and education have contributed to raising awareness of BED as a significant mental health condition. During the National Eating Disorders Awareness Week in February 2024, Monte Nido & Affiliates conducted an educative session on binge eating disorder. As a leading eating disorder treatment provider in the United States, they offer vital resources and expanded virtual treatment programs in 28 states. Their specialty program addresses core features of shame, guilt, and self-blame associated with binge eating disorder, encouraging individuals to seek help for mental health issues without fear of judgment has led to an increase in early diagnoses. Healthcare providers have improved their skills in recognizing BED, resulting in an increased need for treatment choices.

Binge Eating Disorder Market Trends

The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:

Advances in Treatments

Progress in treatments is leading to a rise in the need for medication-based therapies that focus on the neurological and psychological components of BED. Continued studies on novel drugs are expanding the range of treatment options, as pharmaceutical companies are funding clinical trials to create better treatments with reduced side effects. This is helping to tailor treatment plans to individuals and maintain market growth for treatments of BED.

Rising Use of Non-Invasive Therapies to Boost Binge Eating Disorder Market Value

Non-intrusive treatments like cognitive behavioral therapy (CBT) are gaining popularity for addressing BED. These treatments concentrate on altering eating habits and emotional cues without requiring invasive techniques. Treatment plans also incorporate group therapy, family counseling, and nutritional education among others. 

Rising Focus on Mental Health in Corporate Wellness Programs

The increasing focus on mental health in company wellness initiatives is resulting in the inclusion of resources for the condition. Businesses are broadening their benefits packages to incorporate therapy, counseling, and stress management initiatives to tackle the consequences of untreated binge eating disorders. Educational workshops on eating disorders are being integrated to increase awareness and encourage early intervention. 

Use of Digital Therapeutics

Digital therapeutics are influencing the treatment of BED by providing accessible resources such as mobile apps and online platforms for self-directed programs and cognitive behavioral therapy. These electronic tools enable people to monitor their symptoms in real-time and get remote assistance via telehealth services, especially helping younger patients and those in disadvantaged regions. The demand for digital therapeutics in treating BED is rising due to their cost efficiency and effectiveness.

Binge Eating Disorder Market Segmentation

Market Breakup by Drug Class

• Antidepressant
• Anticonvulsant 
• Anti-obesity Medication 
• Others 

Market Breakup by Route of Administration

• Oral 
• Parenteral 
• Others 

Market Breakup by Distribution Channel

• Hospital Pharmacy 
• Retail Pharmacy 
• Online Pharmacy 
• Others 

Market Breakup by Region

• United States 
• EU-4 and the United Kingdom 
  • Germany 
  • France 
  • Italy 
  • Spain 
  • United Kingdom 
• Japan 
• India

Binge Eating Disorder Market Share

Market Share Based on Route of Administration to Witness Substantial Growth

Based on the route of administration, the market is divided into oral, parenteral, and others. The most frequent administration is through oral administration, where drugs such as lisdexamfetamine and antidepressants can be easily included in daily schedules. Oral medications allow for flexibility in dosage and self-administration, increasing accessibility and affordability for long-term treatment. 

Binge Eating Disorder Market Analysis by Region

Based on region, the market report covers the United States, EU-4 (Germany, France, Italy, Spain), United Kingdom, Japan, and India.

The United States is expected to dominate the market because of the high prevalence of the disorder and the availability of advanced treatment options, along with extensive awareness initiatives and strong healthcare facilities encouraging treatment acceptance. Drugs such as lisdexamfetamine and treatments like CBT are frequently utilized, supported by insurance and government efforts. 

There has been a significant increase in market growth in the EU-4 countries and the United Kingdom due to the rising awareness of eating disorders as serious health issues, leading to more investment in mental health services and a higher demand for treatments. The market in Japan and India is rapidly expanding driven by greater awareness, diagnosis rates,h ealthcare infrastructure enhancements, lifestyle modifications, urbanization, and stress.

Leading Players in the Binge Eating Disorder Market

The key features of the market report include patent analysis, grant analysis, funding, and investment analysis, clinical trials analysis as well as strategic initiatives by the leading players. The major companies in the market are as follows:

Tonix Pharmaceuticals Holding Corp

Tonix Pharmaceuticals is a biopharmaceutical company dedicated to creating new treatments for central nervous system disorders, immunology conditions, infectious diseases, and rare diseases. In July 2023, they started enrolling participants in the MGH Phase 2 'STROBE' Study of TNX-1900 (Intranasal Potentiated Oxytocin) for the treatment of binge-eating disorder in July 2023.

Chronos Therapeutics Limited

Chronos Therapeutics Ltd is a UK-based pharmaceutical company focused on developing drugs for neurodegenerative diseases. They are a major player in the binge eating disorder market, utilizing Orexin -1 Antagonist research for effective treatment with minimal side effects.

Pyramid Healthcare Inc.

Pyramid Healthcare offers a range of healthcare services in the United States, including residential and outpatient treatment, dual diagnosis, mental health, transitional housing, and specialty programs for substance abuse, mental health, autism, and eating disorders.

Eli Lilly and Company 

Eli Lilly and Company in Indianapolis, Indiana is a healthcare company developing medications for various health conditions. The FDA approved Lilly's Zepbound (tirzepatide) in November 2023 for chronic weight management, providing a new treatment option for those struggling with obesity or being overweight with weight-related medical issues. 

Other players in the market are Takeda Pharmaceutical Company Limited, VIVUS LLC, Sunovion Pharmaceuticals Inc., H. Lundbeck A/S, Orexigen Therapeutics Inc., Jazz Pharmaceuticals Inc., and Novo Nordisk A/S. 

Key Questions Answered in the Binge Eating Disorder Market Report

• What was the binge eating disorder market value in 2023? 
• What is the binge eating disorder market forecast outlook for 2024-2032? 
• What are the regional markets covered in the EMR report?
• What is the market segmentation based on drug class? 
• What is the market segmentation based on the route of administration? 
• What is the market breakup based on distribution channels?
• What are the major factors aiding the binge eating disorder market demand? 
• How has the market performed so far and how is it anticipated to perform in the coming years? 
• What are the major drivers, opportunities, and restraints in the market?
• What are the major trends influencing the market?
• Which regional market is expected to dominate the market share in the forecast period?
• Which country is likely to experience elevated growth during the forecast period?
• Who are the key players involved in the binge eating disorder market? 
• What are the current unmet needs and challenges in the market? 
• How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?